RiboX Therapeutics Ltd.
2 clinical trials · Sponsor
◉ Watch RiboX Therapeutics Ltd.
| Record | Firm | Date |
|---|---|---|
| Phase 1 Dose Escalation Study of RXIM002 in Autoimmune Cytopenias (NCT07765966) | RiboX Therapeutics Ltd. | 2027-02-01 |
| Study of Circular RNA Treatment in Patients With Radiation Induced Xerostomia-1 (NCT06714253) | RiboX Therapeutics Ltd. | 2025-03-05 |
Track RiboX Therapeutics Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.